Rifkin A, Rieder E, Sarantakos S, Saraf K, Kane J
Am J Psychiatry. 1984 Nov;141(11):1411-3. doi: 10.1176/ajp.141.11.1411.
The authors compared loxapine with chlorpromazine in inpatients with paranoid schizophrenia and found no difference in clinical efficacy. Thus a previous finding, based on retrospective analyses, that loxapine was superior to other neuroleptics in the treatment of paranoid schizophrenia was not verified in this prospective study.
作者将洛沙平与氯丙嗪用于偏执型精神分裂症住院患者,并发现两者临床疗效无差异。因此,一项基于回顾性分析得出的先前研究结果,即洛沙平在治疗偏执型精神分裂症方面优于其他抗精神病药物,在这项前瞻性研究中未得到证实。